Shire

FTSE Russell notes the scheme of arrangement between Shire (UK, B2QKY05, GEIS Large Cap, FTSE 100) and Takeda Pharmaceutical (Japan, 6870445, GEIS Large Cap), whereby Shire shareholder will receive 30.22 USD and 0.839 Takeda Pharmaceutical shares for each share held.

Subject to shareholder approval and based on the current timetable, FTSE Russell anticipates the following treatment:

Wednesday 02 January 2019 (at market close):

For the indexes with a fixed number of constituents from which Shire will be deleted (including the FTSE 100 Index), the reserve lists will be ranked based on closing prices, with the highest ranking reserve constituent selected to replace Shire. Further notices will be published to confirm membership changes.

Tokyo Stock Exchange holiday.

Thursday 03 January 2019:

Tokyo Stock Exchange holiday.

Friday 04 January 2019:

Last day of dealings in Shire.

Monday 07 January 2019 (from market open):

Shire will be deleted from FTSE Russell Indexes concurrent with an associated increase in shares of Takeda Pharmaceutical, and all other index changes (as notified prior) become effective.

FTSE Russell will issue further notices in due course and with the provision of advance notice.

Please note: The above projected implementation schedule follows standard merger treatment and based on the published scheme timetable. Index users are welcome to provide comments in advance of index implementation. 

For further information please contact FTSE Russell Client Services at [email protected] or call:

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2018 FTSE Russell